Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Observational study of pirfenidone effect on cough in idiopathic pulmonary fibrosis
NL-OMON41593Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of pirfenidone in idiopathic pulmonary fibrosis (IPF), sponsored by Erasmus MC. Primary endpoint: Change in cough frequency. Started Dec 2013; status: active, not recruiting.
02
Drugs
pirfenidone
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NL-OMON41593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41593.